688580 伟思医疗
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.3288.6376.12912.10017.360
总资产报酬率 ROA (%)1.2087.8085.64711.18614.775
投入资产回报率 ROIC (%)1.3038.4445.98411.71610.019

边际利润分析
销售毛利率 (%)70.18471.76472.47874.78173.634
营业利润率 (%)25.80532.11532.47845.27043.572
息税前利润/营业总收入 (%)19.75328.56427.03142.04442.318
净利润/营业总收入 (%)24.81229.47929.17341.28337.829

收益指标分析
经营活动净收益/利润总额(%)67.28976.78370.47077.58184.187
价值变动净收益/利润总额(%)4.9896.41015.12710.4148.084
营业外收支净额/利润总额(%)0.4491.0461.3071.3690.734

偿债能力分析
流动比率 (X)10.5348.27310.20713.81011.027
速动比率 (X)10.1788.0109.93813.51610.738
资产负债率 (%)8.2199.9269.2436.4498.404
带息债务/全部投入资本 (%)-0.0520.3060.8342.099--
股东权益/带息债务 (%)-189,619.70132,005.58211,681.9854,659.0292,313.762
股东权益/负债合计 (%)1,116.663907.439981.9201,450.6671,086.116
利息保障倍数 (X)-3.202-7.343-4.599-10.909-26.850

营运能力分析
应收账款周转天数 (天)37.65022.48125.41815.5730.000
存货周转天数 (天)139.770103.095132.738112.1100.000